Clearmind Medicine Inc [NASDAQ: CMND] plunged by -$0.09 during the normal trading session on Thursday and reaching a high of $0.9715 during the day while it closed the day at $0.91.
Clearmind Medicine Inc stock has also loss -7.68% of its value over the past 7 days. However, CMND stock has declined by -6.51% in the 3 months of the year. Over the past six months meanwhile, it has lost -11.09% and lost -36.13% year-on date.
The market cap for CMND stock reached $4.96 million, with 5.38 million shares outstanding and 3.10 million shares in the current float. Compared to the average trading volume of 692.82K shares, CMND reached a trading volume of 5044218 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Clearmind Medicine Inc [CMND]:
The Price to Book ratio for the last quarter was 4.58, with the Price to Cash per share for the same quarter was set at 0.64.
CMND stock trade performance evaluation
Clearmind Medicine Inc [CMND] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.68. With this latest performance, CMND shares dropped by -10.21% in over the last four-week period, additionally sinking by -11.09% over the last 6 months – not to mention a drop of -34.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CMND stock in for the last two-week period is set at 39.03, with the RSI for the last a single of trading hit 0.0737, and the three-weeks RSI is set at 0.0657 for Clearmind Medicine Inc [CMND]. The present Moving Average for the last 50 days of trading for this stock 1.0104, while it was recorded at 0.9814 for the last single week of trading, and 1.0627 for the last 200 days.
Clearmind Medicine Inc (CMND) Capital Structure & Debt Analysis
According to recent financial data for Clearmind Medicine Inc. ( CMND), the Return on Equity (ROE) stands at -178.64%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -66.77%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Clearmind Medicine Inc’s Return on Invested Capital (ROIC) is -380.41%, showcasing its effectiveness in deploying capital for earnings.
Clearmind Medicine Inc (CMND) Efficiency & Liquidity Metrics
Based on Clearmind Medicine Inc’s (CMND) latest financial statements, the Debt-to-Equity Ratio is 0.03%, indicating its reliance on debt financing relative to shareholder equity.
Clearmind Medicine Inc (CMND) Efficiency & Liquidity Metrics
Clearmind Medicine Inc [CMND]: Institutional Ownership
There are presently around $10.96%, or 11.27%% of CMND stock, in the hands of institutional investors.
